NCT03998176 Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Patients With Active Illicit Substance usE Status COMPLETED Phase PHASE4
NCT03961438 Amsterdam UMC Clinical Trial With a Native-like HIV-1 Envelope Vaccine Status COMPLETED Phase PHASE1
NCT03960645 Study to Evaluate the Pharmacokinetics (PK), Safety, and Efficacy of B/F/TAF in Human Immunodeficiency Virus (HIV)-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third Trimesters Status COMPLETED Phase PHASE1
NCT03940521 Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03913195 Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection Status COMPLETED Phase PHASE3
NCT03875209 10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults Status COMPLETED Phase PHASE1
NCT03837756 Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV Status COMPLETED Phase PHASE2
NCT03837015 Estrogen, Probiotics and Vaginal Health to Prevent HIV Infection in ACB Women Status COMPLETED Phase PHASE1
NCT03834909 Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P) Status WITHDRAWN Phase PHASE1
NCT03825536 Effect of Methamphetamine on Residual Latent HIV Disease Study Status COMPLETED Phase PHASE4
NCT03816137 Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens Status COMPLETED Phase PHASE1
NCT03813979 Pharmacokinetics of Single-dose Dolutegravir in HIV-seronegative Subjects With Severe Hepatic Impairment Compared to Matched Controls. Status WITHDRAWN Phase PHASE4
NCT03757117 Gender-Affirmative Transgender Care to Improve the HIV Treatment Cascade Status COMPLETED Phase PHASE4